MAM
Meeder Asset Management Portfolio holdings
AUM
$1.63B
1-Year Return
27.94%
This Quarter Return
+5.37%
1 Year Return
+27.94%
3 Year Return
+116.82%
5 Year Return
+187.4%
10 Year Return
+462.19%
AUM
$1.44B
AUM Growth
-$55.6M
(-3.7%)
Cap. Flow
-$64.5M
Cap. Flow
% of AUM
-4.48%
Top 10 Holdings %
Top 10 Hldgs %
49.1%
Holding
1,044
New
203
Increased
265
Reduced
345
Closed
138
Top Buys
| 1 |
Microsoft
MSFT
|
$45.1M |
| 2 |
Costco
COST
|
$35.1M |
| 3 |
Mastercard
MA
|
$30.9M |
| 4 |
Tesla
TSLA
|
$27.7M |
| 5 |
Masco
MAS
|
$17.2M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$48.5M |
| 2 |
Netflix
NFLX
|
$31.1M |
| 3 |
AbbVie
ABBV
|
$30.4M |
| 4 |
Johnson & Johnson
JNJ
|
$26.1M |
| 5 |
Ross Stores
ROST
|
$14.7M |
Sector Composition
| 1 | Technology | 30.97% |
| 2 | Financials | 18.15% |
| 3 | Consumer Discretionary | 14.73% |
| 4 | Communication Services | 8.57% |
| 5 | Industrials | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Vaxcyte
PCVX
$4.29B
| $4.26K | ﹤0.01% |
52
-646
| -93% | -$52.9K |
|
|
BPMC
852
DELISTED
Blueprint Medicines
BPMC
| $4.19K | ﹤0.01% |
48
+2
| +4% | +$174 |
|
853
Crinetics Pharmaceuticals
CRNX
$3.35B
| $4.14K | ﹤0.01% |
81
+5
| +7% | +$256 |
|
854
Krystal Biotech
KRYS
$4.35B
| $4.07K | ﹤0.01% |
+26
| New | +$4.07K |
|
855
Repligen
RGEN
$7.01B
| $4.03K | ﹤0.01% |
28
-1
| -3% | -$144 |
|
856
Casey's General Stores
CASY
$18.8B
| $3.96K | ﹤0.01% |
10
-60
| -86% | -$23.8K |
|
857
SL Green Realty
SLG
$4.4B
| $3.94K | ﹤0.01% |
58
-3
| -5% | -$204 |
|
|
PGRE
858
Paramount Group
PGRE
$1.66B
| $3.94K | ﹤0.01% |
+797
| New | +$3.94K |
|
859
Sarepta Therapeutics
SRPT
$1.96B
| $3.89K | ﹤0.01% |
32
-514
| -94% | -$62.5K |
|
860
Revolution Medicines
RVMD
$7.57B
| $3.85K | ﹤0.01% |
88
-14
| -14% | -$612 |
|
861
Americold
COLD
$3.98B
| $3.72K | ﹤0.01% |
174
-21
| -11% | -$449 |
|
862
UGI
UGI
$7.43B
| $3.7K | ﹤0.01% |
131
-3,639
| -97% | -$103K |
|
863
FMC
FMC
$4.72B
| $3.65K | ﹤0.01% |
75
-5
| -6% | -$243 |
|
864
Estee Lauder
EL
$32.1B
| $3.6K | ﹤0.01% |
48
-10
| -17% | -$750 |
|
865
Cytokinetics
CYTK
$6.34B
| $3.58K | ﹤0.01% |
+76
| New | +$3.58K |
|
866
Cleveland-Cliffs
CLF
$5.63B
| $3.46K | ﹤0.01% |
368
+14
| +4% | +$132 |
|
867
Arcellx
ACLX
$4.03B
| $3.45K | ﹤0.01% |
+45
| New | +$3.45K |
|
868
Macerich
MAC
$4.74B
| $3.45K | ﹤0.01% |
173
-9
| -5% | -$179 |
|
869
Rocket Pharmaceuticals
RCKT
$354M
| $3.38K | ﹤0.01% |
+269
| New | +$3.38K |
|
870
Lyft
LYFT
$6.91B
| $3.38K | ﹤0.01% |
+262
| New | +$3.38K |
|
871
International Seaways
INSW
$2.31B
| $3.38K | ﹤0.01% |
94
+38
| +68% | +$1.37K |
|
872
Denali Therapeutics
DNLI
$2.26B
| $3.36K | ﹤0.01% |
165
+6
| +4% | +$122 |
|
873
Lumen
LUMN
$4.87B
| $3.3K | ﹤0.01% |
622
-25
| -4% | -$133 |
|
874
Dollar General
DG
$24.1B
| $3.26K | ﹤0.01% |
43
-2
| -4% | -$152 |
|
|
ALTM
875
DELISTED
Arcadium Lithium plc
ALTM
| $3.16K | ﹤0.01% |
616
-448
| -42% | -$2.3K |
|